Gene · 442918
Papers2,004
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 2,004
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| MicroRNAs as Molecular Biomarkers for the Characterization of Basal-like Breast Tumor Subtype. | Biomedicines | 2023 | 38002007 | PubTator, text mining | PubMed |
| The Diversity of Liquid Biopsies and Their Potential in Breast Cancer Management. | Cancers (Basel) | 2023 | 38001722 | PubTator, text mining | PubMed |
Integrated Network Analysis of microRNAs, mRNAs, and Proteins Reveals the Regulatory Interaction between hsa-mir-200b and CFL2 Associated with Advanced Stage and Poor Prognosis in Patients with Intestinal Gastric Cancer. | Cancers (Basel) | 2023 | 38001634 | PubTator, text mining | PubMed |
| Dysregulation of Non-Coding RNAs: Roles of miRNAs and lncRNAs in the Pathogenesis of Multiple Myeloma. | Noncoding RNA | 2023 | 37987364 | PubTator, text mining | PubMed |
| Gene dosage compensation: Origins, criteria to identify compensated genes, and mechanisms including sensor loops as an emerging systems-level property in cancer. | Cancer Med | 2023 | 37987212 | PubTator, text mining | PubMed |
| Identification ferroptosis-related hub genes and diagnostic model in Alzheimer's disease. | Front Mol Neurosci | 2023 | 37965040 | PubTator, text mining | PubMed |
| Unraveling the Potential of miRNAs from CSCs as an Emerging Clinical Tool for Breast Cancer Diagnosis and Prognosis. | Int J Mol Sci | 2023 | 37958993 | PubTator, text mining | PubMed |
A Retrospective Exploratory Analysis for Serum Extracellular Vesicles Reveals APRIL (TNFSF13), CXCL13, and VEGF-A as Prognostic Biomarkers for Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer. | Int J Mol Sci | 2023 | 37958571 | PubTator, text mining | PubMed |
| Rapid in situ RNA imaging based on Cas12a thrusting strand displacement reaction. | Nucleic Acids Res | 2023 | 37941139 | PubTator, text mining | PubMed |
| Exploration of the common pathogenic link between COVID-19 and diabetic foot ulcers: An in silico approach. | Health Sci Rep | 2023 | 37936615 | PubTator, text mining | PubMed |
| Small RNAs, spermatogenesis, and male infertility: a decade of retrospect. | Reprod Biol Endocrinol | 2023 | 37924131 | PubTator, text mining | PubMed |
| PDZ and LIM Domain-Encoding Genes: Their Role in Cancer Development. | Cancers (Basel) | 2023 | 37894409 | PubTator, text mining | PubMed |
| Nuclear lncRNA NORSF reduces E2 release in granulosa cells by sponging the endogenous small activating RNA miR-339. | BMC Biol | 2023 | 37858148 | PubTator, text mining | PubMed |
| A Narrative Review on CD44's Role in Glioblastoma Invasion, Proliferation, and Tumor Recurrence. | Cancers (Basel) | 2023 | 37835592 | PubTator, text mining | PubMed |
| The Emerging Role of Exosomal miRNAs as Biomarkers for Early Cancer Detection: A Comprehensive Literature Review. | Technol Cancer Res Treat | 2023 | 37817634 | PubTator, text mining | PubMed |
| ESOMIR: a curated database of biomarker genes and miRNAs associated with esophageal cancer. | Database (Oxford) | 2023 | 37815872 | PubTator, text mining | PubMed |
| Expression pattern, prognostic value and potential microRNA silencing of FZD8 in breast cancer. | Oncol Lett | 2023 | 37809047 | PubTator, text mining | PubMed |
| Targeting oncogenic microRNAs from the miR-371~373 and miR-302/367 clusters in malignant germ cell tumours causes growth inhibition through cell cycle disruption. | Br J Cancer | 2023 | 37789102 | PubTator, text mining | PubMed |
| Novel role of immune-related non-coding RNAs as potential biomarkers regulating tumour immunoresponse via MICA/NKG2D pathway. | Biomark Res | 2023 | 37784183 | PubTator, text mining | PubMed |
| Autophagy Modulation as a Potential Therapeutic Strategy in Osteosarcoma: Current Insights and Future Perspectives. | Int J Mol Sci | 2023 | 37762129 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/442918/papers?page=4